Digital twins to advance radiotherapy safety Radiation therapy is commonly used after surgery for various types of cancer, including breast cancer. Despite protection and safety measures, radiation therapy can inadvertently expose the lung and heart to radiation, raising the risk of severe cardiac and pulmonary diseases and secondary tumours.
The EU-funded TETRIS project aims to develop and test personalised risk scores to better predict and mitigate such risks caused by radiation therapy. Researchers will calibrate radiation doses, taking into account patient-specific data from imaging, genetics and transcriptomics. To further improve radioprotection strategies, TETRIS will explore the use of digital twins or virtual replicas of individual patients for enhanced risk assessment and tailored treatment plans.
Fondazione IRCCS Istituto Nazionale dei Tumori
Politecnico di Milano
UniSR Università Vita-Salute San Raffaele
Fundació Privada Institut d’Investigació Oncològica de Vall d’Hebro (VHIO)
Fundación Pública Galega de Medicina Xenómica
Neolys Diagnostics
AQUILAB by Coexya
Region Stockholm Karolinska University Hospital
The main objectives of the TETRIS project are to:
TETRIS
Risk assessment tools for severe side effects after breast radiotherapy: radiation safety through biological extended models and digital twins
EU Grant Agreement n. 101166699